{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","description":"This cluster of papers focuses on the clinical characteristics, epidemiology, immune response, and treatment of Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus. It covers topics such as thrombosis, ACE2 receptor, cytokine storm, and the pandemic's impact on various populations.","keywords":[{"id":"https://openalex.org/keywords/covid-19-pneumonia","display_name":"COVID-19 pneumonia","score":0.5008},{"id":"https://openalex.org/keywords/cytokine-storm","display_name":"cytokine storm","score":0.3937},{"id":"https://openalex.org/keywords/severe-covid-19","display_name":"severe COVID-19","score":0.5828},{"id":"https://openalex.org/keywords/remdesivir","display_name":"remdesivir","score":0.4896},{"id":"https://openalex.org/keywords/pediatric-covid-19","display_name":"pediatric COVID-19","score":0.4842},{"id":"https://openalex.org/keywords/covid-19-treatment","display_name":"COVID-19 treatment","score":0.2132},{"id":"https://openalex.org/keywords/covid-19-severity","display_name":"COVID-19 severity","score":0.3674},{"id":"https://openalex.org/keywords/hyperinflammation","display_name":"hyperinflammation","score":0.257},{"id":"https://openalex.org/keywords/chest-ct-findings","display_name":"chest CT findings","score":0.3637},{"id":"https://openalex.org/keywords/ace2-receptor","display_name":"ACE2 receptor","score":0.2252},{"id":"https://openalex.org/keywords/convalescent-plasma","display_name":"convalescent plasma","score":0.4645},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.2839},{"id":"https://openalex.org/keywords/favipiravir","display_name":"favipiravir","score":0.3403},{"id":"https://openalex.org/keywords/nirmatrelvir-ritonavir","display_name":"nirmatrelvir/ritonavir","score":0.4814},{"id":"https://openalex.org/keywords/laboratory-markers","display_name":"laboratory biomarkers","score":0.2027},{"id":"https://openalex.org/keywords/mild-covid-19","display_name":"mild COVID-19","score":0.4017},{"id":"https://openalex.org/keywords/mild-to-moderate-covid-19","display_name":"mild to moderate COVID-19","score":0.6316},{"id":"https://openalex.org/keywords/molnupiravir","display_name":"molnupiravir","score":0.361},{"id":"https://openalex.org/keywords/il-6-receptor-inhibition","display_name":"IL-6 receptor inhibition","score":0.2271},{"id":"https://openalex.org/keywords/covid-19-complications","display_name":"COVID-19 complications","score":0.2933},{"id":"https://openalex.org/keywords/convalescent-plasma-therapy","display_name":"convalescent plasma therapy","score":0.588},{"id":"https://openalex.org/keywords/il-6-receptor-inhibitor","display_name":"IL-6 receptor inhibitor","score":0.218},{"id":"https://openalex.org/keywords/ct-severity-score","display_name":"CT severity score","score":0.6339},{"id":"https://openalex.org/keywords/crazy-paving-pattern","display_name":"crazy-paving pattern","score":0.4323},{"id":"https://openalex.org/keywords/recovery-trial","display_name":"RECOVERY trial","score":0.6695}],"legacy_keywords":"Clinical Characteristics; SARS-CoV-2; Epidemiology; Thrombosis; Immune Response; ACE2 Receptor; Cytokine Storm; Antiviral Treatment; Pathophysiology; Pandemic","ids":{"openalex":"https://openalex.org/T10041","wikipedia":"https://en.wikipedia.org/wiki/Coronavirus_disease_2019"},"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"},"siblings":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology"},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions"},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research"},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility"},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus"},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment"},{"id":"https://openalex.org/T10976","display_name":"Viral gastroenteritis research and epidemiology"},{"id":"https://openalex.org/T11000","display_name":"Infection Control in Healthcare"},{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research"},{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research"},{"id":"https://openalex.org/T11702","display_name":"Parasitic Diseases Research and Treatment"},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing"},{"id":"https://openalex.org/T12047","display_name":"Viral Infections and Vectors"},{"id":"https://openalex.org/T12107","display_name":"Leprosy Research and Treatment"},{"id":"https://openalex.org/T12116","display_name":"Dermatological diseases and infestations"},{"id":"https://openalex.org/T12297","display_name":"Otolaryngology and Infectious Diseases"},{"id":"https://openalex.org/T12463","display_name":"Amoebic Infections and Treatments"},{"id":"https://openalex.org/T12849","display_name":"Parvovirus B19 Infection Studies"},{"id":"https://openalex.org/T12914","display_name":"Infectious Disease Case Reports and Treatments"},{"id":"https://openalex.org/T13201","display_name":"Infectious Encephalopathies and Encephalitis"}],"works_count":137994,"cited_by_count":2583018,"works_api_url":"https://api.openalex.org/works?filter=topics.id:T10041","updated_date":"2026-10-19T03:01:26","created_date":"2024-01-23T15:27:05"}